SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease -- Ignore unavailable to you. Want to Upgrade?

To: Thai Chung who wrote (2901)2/1/1999 9:16:00 AM
From: David Winkler  Read Replies (2) | Respond to of 3725
 
More controversy
usatoday.com

net impact positive or negative.

Vote here and watch the market. My vote is neutral to negative.

hope I am wrong



To: Thai Chung who wrote (2901)2/1/1999 7:55:00 PM
From: Brian Moloney  Respond to of 3725
 
This is actually a pretty big deal. The premise of the study was originally announced in November 1997. It has the possibility of really cementing the usefulness of the scan in a huge population of people. Unfortunately for the stock, it is a ten year study so I am not sure how this announcement is going to help us at present unless the management has some way of parlaying this into sales.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News